JIN Medical International is expected to go public soon. Here’s what we know about the IPO — and how to buy JIN Medical International stock in Canada when it’s available.
Finder’s top picks on where to buy JIN Medical International stock when it goes public
Finder’s Pick for
Beginners
Finder’s Pick for
Global Trading
Finder’s Pick for
Free Trades
How we chose our Finder’s Picks
We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. You can learn more about our methodology here. We encourage you to compare stock platforms to find one that’s best for your particular budget and goals.Our pick for beginners. We chose CIBC Investor’s Edge for this category because it offers low and competitive fees, as well as an easy-to-use, user-friendly interface and provides a number of learning resources to help you get acquainted with the platform. In addition, students can take advantage of special pricing for making trades if they have a CIBC Student Bank account.Our pick for global trading. We chose Interactive Brokers for this category because it offers extensive trading capabilities and access to advanced trading tools to help traders in their investing journey, as well as access to a large number of international stock exchanges. Our pick for free trades. We chose Wealthsimple for this category because it offers commission-free trading. With no account fee, the mobile app is clean and intuitive to use.
What we know about the JIN Medical International IPO
JIN Medical International filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq Capital Market under the ticker symbol ZJYL. Not yet an official IPO, this is one of the first steps of taking a private company public.
The exact IPO date has not been announced. Stocks are expected to open at a price of $5.00-$6.00. We’ll update this page with more information as it becomes available.
Note: all dollar amounts on this page are in US dollars unless otherwise stated.
How to buy JIN Medical International stock when it starts trading
Once JIN Medical International goes public, you’ll need a brokerage account to invest. Consider opening a brokerage account today so you’re ready as soon as the stock hits the market.
Compare stock trading platforms. Use our comparison table to help you find a platform that fits your needs.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – ZJYL – and research it before deciding if it’s a good investment for you.
Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
Will I be able to buy JIN Medical International stock in Canada?
You won’t be able to buy JIN Medical International stocks on a Canadian stock exchange like the TSX. Instead, you need a Canadian broker that provides access to international stock exchanges.
You can access US exchanges like the NYSE and the NASDAQ using Canadian trading platforms like Qtrade, Wealthsimple, Scotia iTRADE and CIBC Investor’s Edge.
Interactive Brokers provides access to many stock exchanges outside North America like the Hong Kong Stock Exchange (SEHK), Korea Stock Exchange (KSE), National Stock Exchange of India (NSE), Frankfurt Stock Exchange (FWB) and London Stock Exchange (LSE).
How to buy international stocks in Canada
How do similar companies perform?
It’s impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy JIN Medical International stock.
See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.
Rewalk Robotics (RWLK.US)
Company summaryReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.Historical performanceStock informationMarket capitalization: $52413396PEG ratio: 0Dividend yield: 0%Get more detailed information and learn how to buy RWLK.US stock
Invacare Corporation (IVC.US)
Company summaryInvacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers’ representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.Historical performanceStock informationMarket capitalization: $25399862PEG ratio: -0.78Dividend yield: 0.007%Get more detailed information and learn how to buy IVC.US stock
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Tax implications of buying US stocks in Canada
Canadians who earn dividends from US stock investments must pay the US Internal Revenue Service (IRS) a 15% withholding tax on their earnings. The rate goes down to 10% for bonds and other interest-yielding US investments.
An exception is made for stock investments held in trusts designed to provide retirement income. This includes RRIFs, LIRAs, LIFs, LRIFs and Prescribed RRIFs. RRSPs that hold US stocks, bonds or ETFs are also exempt from US withholding tax. RESPs, TFSAs and RDSPs are not exempt.
Canadian and international investment income must be declared on your Canadian tax return. Unless your US earnings are exempt from withholding tax, this means you’ll be taxed by both the IRS and the CRA. The CRA may allow you to claim foreign tax credits for any taxes you’ve already paid to the IRS.
Speak with a tax professional to find out what rules and exceptions apply in your circumstances.
Online stock trading
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
